{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:07:54Z","timestamp":1792843674691,"version":"4.5.0"},"reference-count":102,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The mammalian target of rapamycin (mTOR) signaling pathway regulates cell growth, differentiation, proliferation, and metabolism. Loss\u2010of\u2010function mutations in upstream regulators of mTOR have been highly associated with dysplasias, epilepsy, and neurodevelopmental disorders. These include tuberous sclerosis, which is due to mutations in <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> genes; mutations in <jats:italic>phosphatase and tensin homolog<\/jats:italic> (<jats:italic>PTEN<\/jats:italic>) as in Cowden syndrome, polyhydramnios, megalencephaly, symptomatic epilepsy syndrome (PMSE) due to mutations in the <jats:italic>STE20\u2010related kinase adaptor alpha<\/jats:italic> (<jats:italic>STRADalpha<\/jats:italic>); and neurofibromatosis type 1 attributed to <jats:italic>neurofibromin 1<\/jats:italic> mutations. Inhibition of the mTOR pathway with rapamycin may prevent epilepsy and improve the underlying pathology in mouse models with disrupted mTOR signaling, due to <jats:italic>PTEN<\/jats:italic> or <jats:italic>TSC<\/jats:italic> mutations. However the timing and duration of its administration appear critical in defining the seizure and pathology\u2010related outcomes. Rapamycin application in human cortical slices from patients with cortical dysplasias reduces the 4\u2010aminopyridine\u2013induced oscillations. In the multiple\u2010hit model of infantile spasms, pulse high\u2010dose rapamycin administration can reduce the cortical overactivation of the mTOR pathway, suppresses spasms, and has disease\u2010modifying effects by partially improving cognitive deficits. In post\u2013status epilepticus models of temporal lobe epilepsy, rapamycin may ameliorate the development of epilepsy\u2010related pathology and reduce the expression of spontaneous seizures, but its effects depend on the timing and duration of administration, and possibly the model used. The observed recurrence of seizures and epilepsy\u2010related pathology after rapamycin discontinuation suggests the need for continuous administration to maintain the benefit. However, the use of pulse administration protocols may be useful in certain age\u2010specific epilepsy syndromes, like infantile spasms, whereas repetitive\u2010pulse rapamycin protocols may suffice to sustain a long\u2010term benefit in genetic disorders of the mTOR pathway. In summary, mTOR dysregulation has been implicated in several genetic and acquired forms of epileptogenesis. The use of mTOR inhibitors can reverse some of these epileptogenic processes, although their effects depend upon the timing and dose of administration as well as the model used.<\/jats:p>","DOI":"10.1111\/j.1528-1167.2012.03506.x","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T19:55:42Z","timestamp":1336766142000},"page":"1119-1130","source":"Crossref","is-referenced-by-count":141,"title":["Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target"],"prefix":"10.1111","volume":"53","author":[{"given":"Aristea S.","family":"Galanopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Gorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr393"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03033.x"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2007.11.001"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20211"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10251"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02777.x"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2009.03.003"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4852-10.2011"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4179-08.2009"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5573.1655"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.6.3.11261"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10604"},{"key":"e_1_2_10_14_1","unstructured":"CepedaC Andr\u00e9VM HauptmanJS RaoSP JoshiPR ChenJY MathernGW LevineMS. (2010)Differential sensitivity of cortical neurons to 4\u2010aminopyridine and rapamycin in diverse forms of pediatric epilepsy. Neuroscience Meeting Planner San Diego CA. Program No. 657.9."},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.08.015"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03220.x"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02605.x"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02474.x"},{"key":"e_1_2_10_19_1","first-page":"260","volume-title":"Novartis Found Symp","author":"Crino PB","year":"2007"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02289.x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.07.008"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00353.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(01)00300-X"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2004.08.005"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00976.x"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2010.10.002"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2009.01208.x"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2006.12.003"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296786"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNP.0000149893.12678.44"},{"issue":"14","key":"e_1_2_10_31_1","first-page":"S1","article-title":"Palomid 529, a combined TORC1\/TORC2 inhibitor suppresses spasms in a rat model of infantile spasms","volume":"68","author":"Galanopoulou AS","year":"2010","journal-title":"Ann Neurol"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03391.x"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2001.01428.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2766-06.2006"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1106454108"},{"key":"e_1_2_10_36_1","first-page":"43","article-title":"Expression of tuberin and hamartin in tuberous sclerosis complex\u2010associated and sporadic cortical dysplasia of Taylor\u2019s balloon cell type","volume":"46","author":"Grajkowska W","year":"2008","journal-title":"Folia Neuropathol"},{"key":"e_1_2_10_37_1","unstructured":"HauptmanJS CepedaC AntoniosJ MathernGW LevineMS(2010).The effects of mTOR modulation on the excitability of neocortical neurons and networks.Neuroscience Meeting Planner San Diego CA. Program No. 657.13."},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2009.11.003"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-200311000-00004"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.05.024"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410160511"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1494"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(99)00050-9"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000280579.04974.c0"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503224102"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2008.09.006"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000147727.78571.07"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001671"},{"key":"e_1_2_10_49_1","unstructured":"KumarG MazzuferiM OtoulC JacobsT KaminskiRM. (2011)A randomized blinded preclinical trial of rapamycin in pilocarpine mouse model of chronic epilepsy.Neuroscience Meeting Planner Washington DC. Program No. 560.08."},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-1809.2003.00012.x"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2132711100"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01998.x"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20949"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.002386"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1983.tb04874.x"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70199-X"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000127773.72699.C8"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2011.09.008"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.8.1461"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1391"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20234"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb00452.x"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05117.x"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41592"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02695.x"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.20871"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.131"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02657.x"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2011.088807"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm100"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1131693"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.03.021"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(01)00263-7"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(98)00040-0"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710424105"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2007.09.009"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-008-0706-5"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.11.011"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2007.00059.x"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2009.01018.x"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb02569.x"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.12.051"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(03)00175-2"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03280.x"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.34.4.369"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)01435-2"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10283"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.178"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.14.6269"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03513.x"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000630"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.03.011"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.3.405"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-004-0865-8"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02341.x"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.5698\/1535-7511-11.2.66"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.10.002"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.189589"},{"key":"e_1_2_10_99_1","first-page":"1477","article-title":"Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis","volume":"151","author":"Yeung RS","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21331"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0066-09.2009"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq491"},{"key":"e_1_2_10_103_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5685-08.2009"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2012.03506.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2012.03506.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T01:58:36Z","timestamp":1698631116000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2012.03506.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1528-1167.2012.03506.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03506.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}